Glycomics/Glycoproteomics for Biopharmaceutical and Biotechnology Industries
Wednesday, March 16th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Please join us for a series of three intense investigations into the practicalities required to define, identify, and explore the functions of important biological molecules including glycans, monoclonal antibodies, and oligonucleotides. We outline cutting edge and mainstay analytic tools and protocols, with multiple case studies and practical examples from world leading experts.
Register Free: https://www.biopharminternational.com/bp_w/glycomics
Event Overview:
Join industry-renowned speakers as they share their insights into current and future trends in Biopharma and Biotech applications explored over a three-part webinar series.
Session 1 - Glycomics/Glycoproteomics for the Biopharmaceutical and Biotechnology Industries
Session 2 – Oligonucleotide Analysis and Purification
Session 3 - Industrializing High-Throughput Glycoproteomics Using AI for Clinical Use
Key Learning Objectives:
- Mass Spectrometry-based techniques for analyzing glycosylation with microheterogeneity.
- Mass Spectrometry-based techniques for analyzing glycosylation with macroheterogeneity.
- Quantitative characterization of glycosylation using LC/MRM-MS.
Who Should Attend:
It is intended for those working in biopharmaceutical and biotechnology who want to know about glycomics/glycoproteomics in related analytical methods and applications using mass spectrometry.
Speakers
Hyun Joo An, Ph.D.
Dean, Professor - Graduate School of Analytical Science and Technology, Chungnam National University
Director - Asia-Pacific Glycomics Reference Site, Chungnam National University
Dr. Hyun Joo An is a professor at Chungnam National University (CNU) in the Graduate School of Analytical and Science and Technology. She is also director of the Asia-Pacific Glycomics Reference Site (AGRS), which develops and validates new analytical platforms for glycomic and glycoproteomic analysis in collaboration with government agencies and regional industry. She received her PhD from the University of California at Davis (United States) in 2003 and worked as an associate specialist at UC Davis for 8 years. Professor Hyun Joo An returned to Korea and has been at CNU since 2011. She was also the co-founder of Glycometrix, Inc, an ovarian cancer diagnostic company based on the first glycomics patent for cancer. She is an Agilent Thought Leader Award recipient. She is the on the editorial advisory board of Mass Spectrometry Reviews, Scientific Reports, Bioanalysis, and Journal of Analytical Science and Technology.
Professor Hyun Joo An’s research focuses on bioanalytical mass spectrometry, with applications to glycomics, glycolipidomics, and glycoproteomics. She is developing mass spectrometry-based tools for biopharmaceutical characterization, cancer biomarker discovery, forensic science, and brain glycome mapping. She has authored and co-authored more than 150 peer-reviewed publications on these subjects and holds multiple related patents.
Register Free: https://www.biopharminternational.com/bp_w/glycomics
